BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8713579)

  • 1. Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia.
    Sonoki T; Matsuzaki H; Asou N; Hata H; Matsuno F; Yoshida M; Nagasaki A; Kuribayashi N; Kudo H; Takatsuki K
    Int J Hematol; 1996 Jan; 63(1):71-6. PubMed ID: 8713579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [De novo CD5-positive diffuse large B-cell lymphoma associated with autoimmune hemolytic anemia presenting as erythroid hypoplasia].
    Kuroda H; Matsunaga T; Iyama S; Takimoto R; Shirao S; Kida M; Watanabe H; Konuma Y; Hirayama Y; Kohda K; Niitsu Y
    Rinsho Ketsueki; 2006 Jul; 47(7):633-8. PubMed ID: 16910573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia].
    Huang YQ; Zheng RJ; Wu RJ; Ma XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):722-6. PubMed ID: 27342498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma.
    Fujisawa S; Tanioka F; Matsuoka T; Ozawa T
    Int J Hematol; 2005 May; 81(4):315-8. PubMed ID: 15914362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
    Takai K; Sanada M; Hirose Y; Shibuya H
    Rinsho Ketsueki; 1997 Sep; 38(9):757-62. PubMed ID: 9364867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.
    Harada S; Suzuki R; Uehira K; Yatabe Y; Kagami Y; Ogura M; Suzuki H; Oyama A; Kodera Y; Ueda R; Morishima Y; Nakamura S; Seto M
    Leukemia; 1999 Sep; 13(9):1441-7. PubMed ID: 10482997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma.
    Niwano H; Aoki S; Tsukada N; Toba K; Fuse I; Kishi K; Koike T; Takahashi H; Yamamori S; Shibata A; Aizawa Y
    Ann Hematol; 1997; 75(5-6):221-5. PubMed ID: 9433379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27.
    Uneda S; Gotoh M; Sonoki T; Nishida K; Nakamura Y; Kurimoto M; Hanaoka N; Matsuoka H; Taniwaki M; Nakakuma H
    Int J Hematol; 2008 Dec; 88(5):536-542. PubMed ID: 18972186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD5+ CD10+ extranodal B-cell lymphoma with tetraploid chromosomal abnormality].
    Muat T; Okamura T; Oshima K; Kikuchi M; Niho Y
    Rinsho Ketsueki; 2002 Feb; 43(2):128-31. PubMed ID: 11925876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.
    Kume M; Suzuki R; Yatabe Y; Kagami Y; Miura I; Miura AB; Morishima Y; Nakamura S; Seto M
    Jpn J Cancer Res; 1997 Nov; 88(11):1087-93. PubMed ID: 9439684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
    Murase T; Yamaguchi M; Suzuki R; Okamoto M; Sato Y; Tamaru J; Kojima M; Miura I; Mori N; Yoshino T; Nakamura S
    Blood; 2007 Jan; 109(2):478-85. PubMed ID: 16985183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
    Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
    Tagawa H; Tsuzuki S; Suzuki R; Karnan S; Ota A; Kameoka Y; Suguro M; Matsuo K; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Cancer Res; 2004 Sep; 64(17):5948-55. PubMed ID: 15342373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
    Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
    J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen expression patterns of MYC-rearranged versus non-MYC-rearranged B-cell lymphomas by flow cytometry.
    Mandelker DL; Dorfman DM; Li B; Pozdnyakova O
    Leuk Lymphoma; 2014 Nov; 55(11):2592-6. PubMed ID: 24397618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome).
    Nakamura N; Kuze T; Hashimoto Y; Hoshi S; Tominaga K; Sasaki Y; Shirakawa A; Sato M; Maeda K; Abe M
    Pathol Int; 2000 Aug; 50(8):636-43. PubMed ID: 10972862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.